Seagen Shareholders Approve Pfizer's Acquisition Deal
2023年5月31日 - 5:15AM
Dow Jones News
By Sabela Ojea
Seagen said Tuesday its shareholders voted in favor of Pfizer
buying the company for $43 billion.
The biotechnology cancer specialist continues to expect to close
the deal in late 2023 or early 2024 amid pending regulatory
approvals.
In March, Pfizer said it entered into a definitive merger
agreement with Seagen for $299 per share in cash to invest in
cancer treatments.
The boards of directors of both parties back the
transaction.
Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix
(END) Dow Jones Newswires
May 30, 2023 16:00 ET (20:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
過去 株価チャート
から 3 2024 まで 4 2024
Pfizer (NYSE:PFE)
過去 株価チャート
から 4 2023 まで 4 2024
